High Vaccine Confidence Among Patients in Malaysia

Over the past year, biopharmaceutical companies have worked at an unprecedented speed to research and develop COVID-19 vaccines, treatments and diagnostics – supported by the innovation ecosystem along the way. As regulatory authorities continue to monitor the safety and efficacy of these innovations and authorize them for public use, it is important for patients to also feel confident in and accept inoculation once vaccine supply is available.

EU Commission Cites Systemic IP Barriers in Southeast Asia

Strong intellectual property (IP) protection and enforcement is critical to helping countries attract foreign investment, promote economic growth, provide greater access to medicines and improve patient outcomes. The biennial “Report on the Protection and Enforcement of Intellectual Property Rights in Third Countries” cites Malaysia, Indonesia and Thailand as priority countries that will need to strengthen their IP regulations to stay globally competitive.

IP Protections Help Improve Cancer Screening and Prevention in Malaysia

Cervical cancer is the third most common cancer in women in Malaysia, but the country’s screening rate is disproportionately low. Intellectual property protections are helping to pave the way for a new program to improve screening rates and prevention in Malaysia.